Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients

Authors

• Xiuli Zhang, Washington University School of Medicine in St. Louis
• S Peter Goedegebuure, Washington University School of Medicine in St. Louis
• Michael Y Chen, Washington University School of Medicine in St. Louis
• Rashmi Mishra, Washington University School of Medicine in St. Louis
• Felicia Zhang, Washington University School of Medicine in St. Louis
• Yik Yeung Yu, Washington University School of Medicine in St. Louis
• Kartik Singhal, Washington University School of Medicine in St. Louis
• Lijin Li, Washington University School of Medicine in St. Louis
• Feng Gao, Washington University School of Medicine in St. Louis
• Nancy B Myers, Washington University School of Medicine in St. Louis
• Tammi Vickery, Washington University School of Medicine in St. Louis
• Jasreet Hundal, Washington University School of Medicine in St. Louis
• Michael D McLellan, Washington University School of Medicine in St. Louis
• Mark A Sturmoski, Washington University School of Medicine in St. Louis
• Samuel W Kim, Washington University School of Medicine in St. Louis
• Ina Chen, Washington University School of Medicine in St. Louis
• Jesse T Davidson, Washington University School of Medicine in St. Louis
• Narendra V Sankpal, Washington University School of Medicine in St. Louis
• Stephanie Myles, Washington University School of Medicine in St. Louis
• Rama Suresh, Washington University School of Medicine in St. Louis
• Cynthia X Ma, Washington University School of Medicine in St. Louis
• Ademuyiwa Foluso, Washington University School of Medicine in St. Louis
• Andrea Wang-Gillam, Washington University School of Medicine in St. Louis
• Sherri Davies, Washington University School of Medicine in St. Louis
• Ian S Hagemann, Washington University School of Medicine in St. Louis
• Elaine R Mardis, Washington University School of Medicine in St. Louis
• Obi Griffith, Washington University School of Medicine in St. Louis
• Malachi Griffith, Washington University School of Medicine in St. Louis
• Christopher A Miller, Washington University School of Medicine in St. Louis
• Ted H Hansen, Washington University School of Medicine in St. Louis
• Timothy P Fleming, Washington University School of Medicine in St. Louis
• Robert D Schreiber, Washington University School of Medicine in St. Louis
• William E Gillanders, Washington University School of Medicine in St. Louis

Journal

Genome Medicine

Publication Date

11-14-2024

Volume

16

Issue

1

First Page

131

Document Type

Open Access Publication

DOI

10.1186/s13073-024-01388-3

Rights and Permissions

Zhang, X., Goedegebuure, S.P., Chen, M.Y. et al. Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients. Genome Med 16, 131 (2024). https://doi.org/10.1186/s13073-024-01388-3 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Zhang, Xiuli; Goedegebuure, S Peter; Chen, Michael Y; Mishra, Rashmi; Zhang, Felicia; Yu, Yik Yeung; Singhal, Kartik; Li, Lijin; Gao, Feng; Myers, Nancy B; Vickery, Tammi; Hundal, Jasreet; McLellan, Michael D; Sturmoski, Mark A; Kim, Samuel W; Chen, Ina; Davidson, Jesse T; Sankpal, Narendra V; Myles, Stephanie; Suresh, Rama; Ma, Cynthia X; Foluso, Ademuyiwa; Wang-Gillam, Andrea; Davies, Sherri; Hagemann, Ian S; Mardis, Elaine R; Griffith, Obi; Griffith, Malachi; Miller, Christopher A; Hansen, Ted H; Fleming, Timothy P; Schreiber, Robert D; and Gillanders, William E, "Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients." Genome Medicine. 16, 1. 131 (2024).
https://digitalcommons.wustl.edu/oa_4/6656

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.